|
|
|
|
Patients treated with the atypical anti-psychotic agents clozapine and olanzapine
may be at an increased risk for insulin resistance.
|
|
Dr. Tamer Fouad, M.D.
|
Friday, 21st January 2005
|
|
|
|
|
The FDA was widely criticized for apparent shortcomings of its internal
appeals process for scientists that wish to challenge regulatory decisions.
|
|
Dr. Tamer Fouad, M.D.
|
|
Friday, 5th
November 2004 |
|
|
|
|
Studies show that Vytorin can lower LDL or "bad" cholesterol more effectively than a statin alone.
|
|
Dr. Tamer Fouad, M.D.
|
|
Wednesday, 28th
July 2004 |
|
|
|
|
The FDA issued a warning this month saying
that patients on certain antidepressants should be monitored closely for
warning signs of suicide. |
|
Dr. Tamer Fouad, M.D.
|
|
Monday,
5th April 2004 |
|
|
|
|
Exanta? showed superiority in prevention of thromboembolism
when compared to warfarin.
|
|
Dr. Tamer Fouad, M.D.
|
|
Thursday,
30th October 2003 |
|
|
|
|
The FDA approved Xolair?, the first in a new class of asthma therapies that
are bioengineered to target IgE.
|
|
Dr. Tamer Fouad, M.D.
|
|
Tuesday,
1st July 2003
|
|
|
|
|
Tetracyclines possess properties
that are independent of their antimicrobial characteristics
e.g. arthritis.
|
|
Dr. Safaa Mahmoud, M.D.
|
|
Sunday, 2nd March 2003 |
|
|
|
|
Ibuprofen may counteract the anti-platelet activities of aspirin leading to
increased clot formation.
|
|
Dr. Tamer Fouad, M.D.
|
|
Sunday, 16th February 2003 |
|
|
|
|
Hong Kong research shows Celebrex
may not protect against peptic ulcer or kidney complications of
other NSAIDs.
|
|
Dr. Tamer Fouad, M.D.
|
printer
friendly version
